Search the Newsreel

Natera (NTRA) insider Michael Brophy plans 478-share stock sale after RSU award

Natera insider Michael Brophy has filed a Form 144 notice to sell 478 shares of common stock, valued at $129,232.08, through Morgan Stanley Smith Barney LLC on or about August 4, 2026. These shares were acquired from Restricted Stock Units on July 31, 2026. …

RingCentral insider plans sale of 10,000 Class A shares | RNG SEC Filing - Form 144

RingCentral insider Vlad Vendrow has filed a Form 144, indicating an intent to sell 10,000 shares of Class A common stock with a proposed aggregate value of $600,308.00 through Morgan Stanley Smith Barney LLC. These shares were initially received as a gift from an …

Natera Deadline Alert

Faruqi & Faruqi, LLP is investigating potential claims against Natera, Inc. (NASDAQ: NTRA) and reminds investors of the June 27, 2022 deadline to seek the role of lead plaintiff in a federal securities class action. The lawsuit alleges Natera made false and misleading statements …

Price to book forward of K W Nelson Interior Design and Contracting Group Limited – HKEX:8411

Enterprise value to revenue forward of Central China New Life Ltd. – HKEX:9983

Central Asia Metals (LON:CAML) Stock Passes Below Two Hundred Day Moving Average - What's Next?

Entravision Communications (EVC) Pulls Back After A Strong Rebound, Is The Premium Already Too High?

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Receives Average Recommendation of "Hold" from Brokerages

Entrada Therapeutics, Inc. (NASDAQ:TRDA) has received an average "Hold" recommendation from brokerages, based on a mix of sell, hold, and buy ratings, with an average 12-month price target of $17.50. The company's shares opened at $7.26 and have traded between $4.93 and $16.45 over …

CENTRAL BANCOMPANY ($CBC) Releases Q2 2026 Earnings

Earnings Flash (CBC) Central Bancompany, Inc. Reports Q2 Revenue $282.3M

Earnings Flash (CBC) Central Bancompany, Inc. Posts Q2 Adjusted EPS $0.47 per Share

Central Bancompany GAAP EPS of $0.47 in-line, revenue of $282.34M misses by $1.43M

* Central Bancompany, Inc. press release [https://seekingalpha.com/pr/20605672-central-bancompany-inc-reports-second-quarter-2026-results-declares-regular-0_12-dividend-and] (CBC [https://seekingalpha.com/symbol/CBC]): Q2 GAAP EPS of $0.47 in-line. * Revenue of $282.34M (+15.2% Y/Y) misses by $1.43M. * Net interest income of $212.8 million, reflecting a net interest margin (“NIM”) of 4.40% compared to 4.32% in the …

Concentra Group Holdings Parent (CON) Stock Analysis: Robust Growth and Strong Buy Ratings Fuel Investor Optimism

Concentra Group Holdings Parent (CON) is showing strong growth in the healthcare sector, with a robust revenue increase of 13.70% and an impressive return on equity of 47.00%. The company's stock, currently at $31.70, has a positive outlook from analysts, with nine buy ratings …

(CENTA) and the Role of Price-Sensitive Allocations

This article analyzes Central Garden & Pet Company Class A Common Stock Nonvoting (NASDAQ: CENTA), highlighting weak near-term sentiment despite potential long-term strength. It details three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored to different risk profiles. The analysis also includes multi-timeframe …

Entrada Therapeutics director, 10% owner Kush Parmar disposes of $807,529 in common shares

Entrada Therapeutics director and 10% owner Kush Parmar sold 116,474 common shares on July 30-31, totaling $807,529. These transactions reduced 5AM Ventures V's stake to 2,846,592 shares, while 5AM Opportunities I held 1,093,313 shares afterward. This news brief was generated by AI based on …

Earnings To Watch: Central Garden & Pet (CENT) Reports Q2 Results Tomorrow

Central Garden & Pet (NASDAQ:CENT) is set to report its Q2 earnings tomorrow, with analysts expecting a year-over-year revenue decline of 8.8%. The company beat revenue and EBITDA estimates last quarter, but has missed Wall Street's revenue estimates multiple times in the past two …

LIC Shares Sale Puts CDSL Stock And Indian Financials In Focus

Entrada Therapeutics director Kush Parmar sells $807,027 in shares

Kush Parmar, a director and 10% owner of Entrada Therapeutics (NASDAQ:TRDA), recently sold $807,027 worth of company shares through 5AM Ventures V, L.P., across two transactions on July 30 and 31, 2026. The sales occurred as TRDA stock surged 24.53% over the past week …

5am Ventures V sells $807,027 of Entrada Therapeutics stock

5AM Ventures V, L.P., a significant owner and director of Entrada Therapeutics (NASDAQ:TRDA), recently sold shares worth $807,027. These transactions occurred over two days, with shares sold at prices between $6.85 and $6.93, even as the stock has surged 24.5% in the past week …

Form 4 Entrada Therapeutics Inc For: 4 August By Investing.com

This article from Investing.com is a minimal announcement regarding a Form 4 filing for Entrada Therapeutics Inc, dated August 4. It provides the stock symbol TRDA and notes a -2.20% change. The content primarily consists of navigation, advertisements, and market data rather than detailed …

NTRA 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Natera, Inc. (NTRA) Investors with Losses to Contact Firm's Attorneys Before June 27th Deadline in Securities Class Action

Hagens Berman, National Trial Attorneys, is urging investors of Natera, Inc. (NTRA) who have suffered significant losses to contact their attorneys before the June 27th deadline for a securities class action lawsuit. The lawsuit alleges that Natera misrepresented the reliability and superiority of its …

SF Intra-city’s profit doubles on growing scale

RingCentral (RNG) Is Up 15.1% After Raising 2026 Guidance And Boosting Capital Returns – Has The Bull Case Changed?

RingCentral's stock rose 15.1% after reporting higher revenue and net income, raising its 2026 earnings guidance, and increasing its quarterly dividend. The company also announced an expanded partnership with NiCE, integrating AI-enabled communications into its business model. Despite these positive developments, the article notes …

Neutral Position Drives High-Quality Growth Across All Scenarios: SF Intra-city (9699.HK) Releases Positive Profit Alert for First Half 2026

Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: Should You Buy?

Kyntra Bio (KYNB) is anticipated to surpass earnings estimates for the quarter ended June 2026, with a projected year-over-year increase in earnings and revenues. The company's positive Earnings ESP of +5.44% combined with a Zacks Rank #3 suggests a strong likelihood of an EPS …

Entrada Therapeutics (TRDA) holder sells shares, still reports 1.09M stake

5AM Ventures V, L.P., a ten percent shareholder of Entrada Therapeutics (TRDA), reported selling a total of 116,474 shares of common stock on July 30-31, 2026, with transactions occurring at a weighted average price of $6.93 per share. Despite these sales, affiliated entity 5AM …

Natera (NTRA) insider Solomon Moshkevich files to sell 12,720 shares

Solomon Moshkevich, an insider at Natera (NTRA), has filed a Form 144 to sell up to 12,720 shares of common stock, with a proposed sale date on or after July 31, 2026. These shares were acquired as Restricted Stock Units on January 31, 2025, …

Natera (NTRA) insider Jonathan Sheena plans 108-share sale after recent trades

Jonathan Sheena, an insider at Natera, Inc. (NTRA), has filed a notice to sell 108 shares of common stock valued at $28,918.08, with the proposed sale date set for August 3, 2026. The filing also reveals that Sheena holds 3,549 Restricted Stock Units granted …

CONMED (CON) trusts detail 130,000-share planned sale and recent large stock trades

CONMED Corporation's affiliated trusts have filed a Form 144 for the potential sale of 130,000 common shares through UBS Financial Services Inc., with an aggregate market value of $4,114,500. This planned sale represents a small fraction of the 127,961,780 shares outstanding as of August …

Form 144 Concentra Group Holdings Parent For: 3 August By Investing.com

This article announces a Form 144 filing by Concentra Group Holdings Parent for August 3rd. It is a brief, one-line report from Investing.com, providing no additional details or context about the filing. The article also includes a stock market snapshot with various indices and …

Natera (NTRA) holder John Fesko plans Rule 144 sale after prior stock disposals

John Fesko, a shareholder of Natera, Inc. (NTRA), has filed a Rule 144 notice to sell 292 common shares valued at $78,185.92 on NASDAQ, effective August 3, 2026. This planned sale follows four previous open-market disposals of Natera common stock by Fesko in the …

Hangzhou SF Intra-city Signals Strong Profit Surge for First Half of 2026

Hangzhou SF Intra-city Industrial Co., Ltd. Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2026

Is Algoma Central Still One of Canada's Reliable Infrastructure Dividend Stocks? Complete 2026 Outlook

Central Garden & Pet (CENTA) Advances 0.90% as Stock Tests Key Resistance at $40.16 - Mean Reversion Trade

Central Puerto (CEPU) Slips 2% as Shares Test Key Support Near $14.20 - Institutional Flow Picks